Trials / Recruiting
RecruitingNCT06860516
HLA Demographics Study in Adults With Type 1 Diabetes
A Non-interventional Study of HLA-DRB1*04:01 Distribution in Adults With Recently Diagnosed Type 1 Diabetes (T1D)
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (estimated)
- Sponsor
- GentiBio, Inc · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
This is a study to evaluate the HLA-DRB1\*04:01 genotype in adults that have been diagnosed with type 1 diabetes
Detailed description
This is a non-interventional study to evaluate the distribution of human leukocyte antigen (HLA)-DRB1\*04:01 genotype in participants that are recently (within 2 months of the study visit) diagnosed with T1D, with a single blood draw for the analysis of HLA genotype within the study participants. The study duration will be 24 hours and will include a single study visit for the collection of demographic data and a single blood draw, and a follow-up telephone call 24 hours after the study visit.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | blood draw | a blood draw for testing of HLA-DRB1\*04:01 |
Timeline
- Start date
- 2025-06-06
- Primary completion
- 2026-01-30
- Completion
- 2026-06-01
- First posted
- 2025-03-06
- Last updated
- 2025-09-18
Locations
5 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT06860516. Inclusion in this directory is not an endorsement.